Related Experiment Video
Updated: Aug 9, 2026
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers
1Laboratory of Ultrastructure Research, Pathophysiology Unit, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, 464-8681, Nagoya, Japan.
Abstract:
Our previous studies showed that mitotic checkpoint impairment is present in about 40% of human lung cancer cell lines but that mutations in the MAD mitotic checkpoint genes are infrequent. In the present study, we examined 44 lung cancer cases for the potential involvement of the other gene family involved in the mitotic checkpoint, i.e. BUB. We found that the BUB gene family members including BUB1, BUBR1 and BUB3 are not frequent targets for mitotic checkpoint defects in lung cancers, if present at all. Further studies are thus warranted to elucidate the molecular basis for the acquisition of mitotic checkpoint defects in order to better understand the molecular pathogenesis of lung cancers.
Insights
Mitotic checkpoint defects in lung cancer are common, but BUB gene mutations are rare. Further research is needed to understand the molecular causes of these defects in lung cancer pathogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Cell Cycle Regulation
Background:
- Mitotic checkpoint impairment is observed in approximately 40% of human lung cancer cell lines.
- Mutations in MAD mitotic checkpoint genes are infrequent causes of these defects.
Purpose of the Study:
- To investigate the involvement of the BUB gene family in mitotic checkpoint defects in lung cancer.
- To identify potential molecular targets for understanding lung cancer pathogenesis.
Main Methods:
- Analysis of 44 human lung cancer cases.
- Examination of BUB gene family members (BUB1, BUBR1, BUB3) for alterations.
Main Results:
- BUB gene family members (BUB1, BUBR1, BUB3) are not frequently targeted in lung cancers with mitotic checkpoint defects.
- The study found no significant association between BUB gene alterations and mitotic checkpoint defects in the examined lung cancer cases.
Conclusions:
- The BUB gene family does not appear to be a primary driver of mitotic checkpoint defects in the majority of lung cancers studied.
- Further research is necessary to uncover the molecular mechanisms underlying mitotic checkpoint dysfunction in lung cancer.
